| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |